These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 20144675

  • 1. Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits.
    Jardanhazi-Kurutz D, Kummer MP, Terwel D, Vogel K, Dyrks T, Thiele A, Heneka MT.
    Neurochem Int; 2010 Nov; 57(4):375-82. PubMed ID: 20144675
    [Abstract] [Full Text] [Related]

  • 2. Distinct adrenergic system changes and neuroinflammation in response to induced locus ceruleus degeneration in APP/PS1 transgenic mice.
    Jardanhazi-Kurutz D, Kummer MP, Terwel D, Vogel K, Thiele A, Heneka MT.
    Neuroscience; 2011 Mar 10; 176():396-407. PubMed ID: 21129451
    [Abstract] [Full Text] [Related]

  • 3. Gender effect on the accumulation of hyperphosphorylated tau in the brain of locus-ceruleus-injured APP-transgenic mouse.
    Oikawa N, Ogino K, Masumoto T, Yamaguchi H, Yanagisawa K.
    Neurosci Lett; 2010 Jan 14; 468(3):243-7. PubMed ID: 19900506
    [Abstract] [Full Text] [Related]

  • 4. Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease.
    Kalinin S, Gavrilyuk V, Polak PE, Vasser R, Zhao J, Heneka MT, Feinstein DL.
    Neurobiol Aging; 2007 Aug 14; 28(8):1206-14. PubMed ID: 16837104
    [Abstract] [Full Text] [Related]

  • 5. Ear2 deletion causes early memory and learning deficits in APP/PS1 mice.
    Kummer MP, Hammerschmidt T, Martinez A, Terwel D, Eichele G, Witten A, Figura S, Stoll M, Schwartz S, Pape HC, Schultze JL, Weinshenker D, Heneka MT, Urban I.
    J Neurosci; 2014 Jun 25; 34(26):8845-54. PubMed ID: 24966384
    [Abstract] [Full Text] [Related]

  • 6. Late onset loss of hippocampal 5-HT and NE is accompanied by increases in BDNF protein expression in mice co-expressing mutant APP and PS1.
    Szapacs ME, Numis AL, Andrews AM.
    Neurobiol Dis; 2004 Aug 25; 16(3):572-80. PubMed ID: 15262269
    [Abstract] [Full Text] [Related]

  • 7. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
    Arendash GW, Jensen MT, Salem N, Hussein N, Cracchiolo J, Dickson A, Leighty R, Potter H.
    Neuroscience; 2007 Oct 26; 149(2):286-302. PubMed ID: 17904756
    [Abstract] [Full Text] [Related]

  • 8. Comparisons of neuroinflammation, microglial activation, and degeneration of the locus coeruleus-norepinephrine system in APP/PS1 and aging mice.
    Cao S, Fisher DW, Rodriguez G, Yu T, Dong H.
    J Neuroinflammation; 2021 Jan 06; 18(1):10. PubMed ID: 33407625
    [Abstract] [Full Text] [Related]

  • 9. Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP/PS1 transgenic mice.
    Zhang J, Guo J, Zhao X, Chen Z, Wang G, Liu A, Wang Q, Zhou W, Xu Y, Wang C.
    Behav Brain Res; 2013 Aug 01; 250():230-7. PubMed ID: 23685322
    [Abstract] [Full Text] [Related]

  • 10. Long-term social isolation exacerbates the impairment of spatial working memory in APP/PS1 transgenic mice.
    Huang HJ, Liang KC, Ke HC, Chang YY, Hsieh-Li HM.
    Brain Res; 2011 Jan 31; 1371():150-60. PubMed ID: 21114967
    [Abstract] [Full Text] [Related]

  • 11. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K, Zhao H, Zhang C, He N, Shen H, Wang Z, Zhao W, Yin M.
    J Neurol Sci; 2013 Dec 15; 335(1-2):145-54. PubMed ID: 24095271
    [Abstract] [Full Text] [Related]

  • 12. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
    Melnikova T, Savonenko A, Wang Q, Liang X, Hand T, Wu L, Kaufmann WE, Vehmas A, Andreasson KI.
    Neuroscience; 2006 Sep 01; 141(3):1149-62. PubMed ID: 16753269
    [Abstract] [Full Text] [Related]

  • 13. BACE/APPV717F double-transgenic mice develop cerebral amyloidosis and inflammation.
    Ozmen L, Woolley M, Albientz A, Miss MT, Nelboeck P, Malherbe P, Czech C, Gruninger-Leitch F, Brockhaus M, Ballard T, Jacobsen H.
    Neurodegener Dis; 2005 Sep 01; 2(6):284-98. PubMed ID: 16909011
    [Abstract] [Full Text] [Related]

  • 14. Early temporal short-term memory deficits in double transgenic APP/PS1 mice.
    Lagadec S, Rotureau L, Hémar A, Macrez N, Delcasso S, Jeantet Y, Cho YH.
    Neurobiol Aging; 2012 Jan 01; 33(1):203.e1-11. PubMed ID: 20817351
    [Abstract] [Full Text] [Related]

  • 15. Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice.
    Heneka MT, Ramanathan M, Jacobs AH, Dumitrescu-Ozimek L, Bilkei-Gorzo A, Debeir T, Sastre M, Galldiks N, Zimmer A, Hoehn M, Heiss WD, Klockgether T, Staufenbiel M.
    J Neurosci; 2006 Feb 01; 26(5):1343-54. PubMed ID: 16452658
    [Abstract] [Full Text] [Related]

  • 16. Early detection of memory deficits and memory improvement with vaccinia virus complement control protein in an Alzheimer's disease model.
    Pillay NS, Kellaway LA, Kotwal GJ.
    Behav Brain Res; 2008 Oct 10; 192(2):173-7. PubMed ID: 18490064
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.
    Lee KW, Lee SH, Kim H, Song JS, Yang SD, Paik SG, Han PL.
    J Neurosci Res; 2004 May 15; 76(4):572-80. PubMed ID: 15114629
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Chronic treatment with the α2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APP×PS1 transgenic mice without altering β-amyloid plaque load or astrocytosis.
    Scullion GA, Kendall DA, Marsden CA, Sunter D, Pardon MC.
    Neuropharmacology; 2011 May 15; 60(2-3):223-34. PubMed ID: 20850464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.